Abstract
Today with the advent of chronic illnesses, disability associated with it has found its place as a major contributor to the global burden by impacting lives in all age groups in both developed and developing nations. “Disabilities” roots lie not just in terms of restriction in physical aspects of the patient but also in the context of social, emotional, and mental state too. With an ever-growing aging population prone to disabilities, it is quintessential today to understand the etiology and progression of diseases leading to disability. This chapter aims to focus on the pathogenesis of disease that is likely to cause disability as per the medical and social models of disability.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
A. D. Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37:S81–S90
Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324
Adelman G, Rane SG, Villa KF (2013) The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ 16:639–647
Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J et al (2013) Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2012070718
Ahlsiö B, Britton M, Murray V, Theorell T (1984) Disablement and quality of life after stroke. Stroke 15:886–890
Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S et al (2010) Structural conversion of neurotoxic amyloid-β 1–42 oligomers to fibrils. Nat Struct Mol Biol 17:561
Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, Nemesh J et al (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76
Alzhelmer A (1907) Uber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 64:146–148
Androdias G, Reynolds R, Chanal M, Ritleng C, Confavreux C, Nataf S (2010) Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol 68:465–476
Bartus RT, Dean RR, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414
Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M et al (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 44:328
Bermel RA, Bakshi R (2006) The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 5:158–170
Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332
Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H et al (2010) Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 68:934–943
Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD (2000) Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893–901
Bjartmar C, Wujek J, Trapp B (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165–171
Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS et al (2010) Demyelination versus remyelination in progressive multiple sclerosis. Brain 133:2983–2998
Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving H-H et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869
Bretón RR, Rodríguez JCG (2012) Excitotoxicity and oxidative stress in acute ischemic stroke. In: Acute ischemic stroke. InTech, Croatia
Bromley-Brits K, Song W (2012) The role of TMP21 in trafficking and amyloid-β precursor protein (APP) processing in Alzheimer’s disease. Curr Alzheimer Res 9:411–424
Brooks G, Fahey T, Baldwin K (2005) “Exercise, disease, and disability,” exercise physiology: human bioenergetics and its applications, 4th edn. McGraw Hill: Higher Education, New York, pp 649–680
Brown PO, Botstein D (1999) Exploring the new world of the genome with DNA microarrays. Nat Genet 21:33
Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol, Neurosurg, Psychiatry 25:315
Bruijn L, Beal M, Becher M, Schulz J, Wong P, Price D et al (1997) Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci 94:7606–7611
Burr D (2003) Subchondral bone in the pathogenesis of osteoarthritis. Mechanical aspects. In: Osteoarthritis. Oxford University Press, Oxford, pp 125–133
Cade WT (2008) Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 88:1322–1335
Catrina AI, Joshua V, Klareskog L, Malmström V (2016) Mechanisms involved in triggering rheumatoid arthritis. Immunol Rev 269:162–174
Chaudhury PK, Deka K, Chetia D (2006) Disability associated with mental disorders. Indian J Psychiatr 48:95
Cheng N, Chytil A, Shyr Y, Joly A, Moses HL (2008) Transforming growth factor-β signaling–deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion. Mol Cancer Res 6:1521–1533
Chilelli N, Burlina S, Lapolla A (2013) AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a “glycoxidation-centric” point of view. Nutr Metab Cardiovasc Dis 23:913–919
Chio A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472–476
Choi SR, Howell OW, Carassiti D, Magliozzi R, Gveric D, Muraro PA et al (2012) Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain 135:2925–2937
Cox PA, Sacks OW (2002) Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 58:956–959
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M et al (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–1330
Cummings JL, Arciniegas DB, Brooks BR, Herndon RM, Lauterbach EC, Pioro EP et al (2006) Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 11:1–11
D’Souza B, D’Souza V, Sowmya S, Seema G, Hemalatha C, Anu M et al (2008) A comparative study on oxidative stress and antioxidant status in ischemic stroke patients with and without diabetes. Indian J Clin Biochem 23:218
Dassanayaka S, Jones SP (2015) Recent developments in heart failure. Circ Res 117:e58–e63
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949
Dean J, Keshavan M (2017) The neurobiology of depression: an integrated view. Asian J Psychiatr 27:101–111
Dieppe PA, Lohmander LS (2005) Pathogenesis and management of pain in osteoarthritis. Lancet 365:965–973
Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391–397
Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy-Marchal C (2006) Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J Clin Endocrinol Metab 91:401–404
Drummond K, Mauer M (2002) The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51:1580–1587
Du Yan S, Chen X, Fu J, Chen M, Zhu H, Roher A et al (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer’s disease. Nature 382:685
Du Yan S, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW et al (1997) Amyloid-β peptide–receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci 94:5296–5301
Duckett L (2001) Alzheimer’s dementia: morbidity and mortality. J Insur Med (New York, NY) 33:227–234
Dyck PJ, Kratz K, Karnes J, Litchy WJ, Klein R, Pach J et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817–817
Eikelenboom P, Veerhuis R (1999) The importance of inflammatory mechanisms for the development of Alzheimer’s disease. Exp Gerontol 34:453–461
Feinstein A (2011) Multiple sclerosis and depression. Mult Scler J 17:1276–1281
Felger JC, Lotrich FE (2013) Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246:199–229
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453
Figueroa MS, Peters JI (2006) Congestive heart failure: diagnosis, pathophysiology, therapy, and implications for respiratory care. Respir Care 51:403–412
Fischer MT, Wimmer I, Höftberger R, Gerlach S, Haider L, Zrzavy T et al (2013) Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136:1799–1815
Friedberg EC (2003) DNA damage and repair. Nature 421:436
Gabriel-Costa D (2018) The pathophysiology of myocardial infarction-induced heart failure. Pathophysiology 25(4):277–284
Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J et al (2009) Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol 65:378–385
Gerstein HC (1994) Cow’s milk exposure and type I diabetes mellitus: a critical overview of the clinical literature. Diabetes Care 17:13–19
Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM (1975) Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Investig 55:454–461
Goering S (2015) Rethinking disability: the social model of disability and chronic disease. Curr Rev Musculoskelet Med 8:134–138
Goldring SR (2008) Targeting disease: musculoskeletal conditions. Pharm Res 25(12):2878–2880
Gray E, Paula-Barbosa M, Roher A (1987) Alzheimer’s disease: paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol 13:91–110
Halban PA, Polonsky KS, Bowden DW, Hawkins MA, Ling C, Mather KJ et al (2014) β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab 99:1983–1992
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184
Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E et al (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Investig 122:1791–1802
Harwood CA, McDermott CJ, Shaw PJ (2009) Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler 10:191–204
Heiland EG, Welmer A-K, Wang R, Santoni G, Fratiglioni L, Qiu C (2018) Cardiovascular risk factors and the risk of disability in older adults: variation by age and functional status. J Am Med Dir Assoc. https://doi.org/10.1016/j.jamda.2018.05.013
Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M et al (2006) On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 8:2075–2087
Hertel JKH, Johansson S, Midthjell K, Nygård O, Njølstad PR, Molven A (2013) Type 2 diabetes genes–Present status and data from Norwegian studies. Norsk Epidemiol 23. https://doi.org/10.5324/nje.v23i1.1597
Hinkle JL, Guanci MM (2007) Acute ischemic stroke review. J Neurosci Nurs 39:285–293
Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134:2755–2771
Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F et al (2012) A systematic review of the global prevalence of low back pain. Arthritis Rheum 64:2028–2037
Inamdar A, Inamdar A (2016) Heart failure: diagnosis, management and utilization. J Clin Med 5:62
Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415
Jugdutt BI (2010) Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev 15:401–405
Juhász G, Barkóczi B, Vass G, Datki Z, Hunya Á, Fülöp L et al (2010) Fibrillar Aβ 1-42 enhances NMDA receptor sensitivity via the integrin signaling pathway. J Alzheimers Dis 19:1055–1067
Jurgens CA, Toukatly MN, Fligner CL, Udayasankar J, Subramanian SL, Zraika S et al (2011) β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol 178:2632–2640
Källberg H, Ding B, Padyukov L, Bengtsson C, Rönnelid J, Klareskog L et al (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70:508–511
Kanyal N (2015) The science of ischemic stroke: pathophysiology & pharmacological treatment. Int J Pharma Res Rev 4:65–84
Kasarskis EJ, Lindquist JH, Coffman CJ, Grambow SC, Feussner JR, Allen KD et al (2009) Clinical aspects of ALS in Gulf War veterans. Amyotroph Lateral Scler 10:35–41
Kasarskis EJ, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z et al (2014) Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. Am J Clin Nutr 99:792–803
Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, Woo D, Adeoye O et al (2013) Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke 44:1500–1504
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955
Kilarski LL, Achterberg S, Devan WJ, Traylor M, Malik R, Lindgren A et al (2014) Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24. 12. Neurology 83:678–685
Klijs B, Nusselder WJ, Looman CW, Mackenbach JP (2011) Contribution of chronic disease to the burden of disability. PLoS One 6:e25325
Knudson AG (2002) Cancer genetics. Am J Med Genet 111:96–102
Konig MF, Abusleme L, Reinholdt J, Palmer RJ, Teles RP, Sampson K et al (2016) Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 8:369ra176–369ra176
Korshavn KJ, Bhunia A, Lim MH, Ramamoorthy A (2016) Amyloid-β adopts a conserved, partially folded structure upon binding to zwitterionic lipid bilayers prior to amyloid formation. Chem Commun 52:882–885
Kotler SA, Walsh P, Brender JR, Ramamoorthy A (2014) Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer’s disease. Chem Soc Rev 43:6692–6700
Kotler SA, Brender JR, Vivekanandan S, Suzuki Y, Yamamoto K, Monette M et al (2015) High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification. Sci Rep 5:11811
Krishnamurthy A, Joshua V, Hensvold AH, Jin T, Sun M, Vivar N et al (2016) Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis 75:721–729
Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705–2712
Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218
Lee Y, Lee S-R, Choi SS, Yeo H-G, Chang K-T, Lee HJ (2014) Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke. BioMed Res Int 2014:297241
Lekander I, Willers C, Von Euler M, Lilja M, Sunnerhagen KS, Pessah-Rasmussen H et al (2017) Relationship between functional disability and costs one and two years post stroke. PloS One 12:e0174861
Leonard BE (2001) Stress, norepinephrine and depression. J Psychiatry Neurosci: JPN 26:S11
Lindgren A (2014) Stroke genetics: a review and update. J Stroke 16:114
Lindgren P, Glader E-L, Jönsson B (2008) Utility loss and indirect costs after stroke in Sweden. Eur J Cardiovasc Prev Rehabil 15:230–233
Liu R, Althaus JS, Ellerbrock BR, Becker DA, Gurney ME (1998) Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 44:763–770
Lloyd-Jones D, Adams R, Brown T, Carnethon M, Dai S, De Simone G et al (2010) Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 121:e46
Lorenzo-Almoros A, Tunon J, Orejas M, Cortés M, Egido J, Lorenzo Ó (2017) Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol 16:28
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128
Luengo-Fernandez R, Paul NL, Gray AM, Pendlebury ST, Bull LM, Welch SJ et al (2013) Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke 44:2854–2861
Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ (2010) Epidemiology of type 1 diabetes. Endocrinol Metab Clin 39:481–497
Machado-Vieira R, Salvadore G, DiazGranados N, Ibrahim L, Latov D, Wheeler-Castillo C et al (2010) New therapeutic targets for mood disorders. Sci World J 10:713–726
Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183–193
Maher P, Davis JB (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16:6394–6401
Marburg O (1906) Die sogenannte akute multiple Sklerose: Рипол Классик.
March L, Smith EU, Hoy DG, Cross MJ, Sanchez-Riera L, Blyth F et al (2014) Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol 28:353–366
McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389:2328–2337
Mehta S, Vemuganti R (2014) Mechanisms of stroke induced neuronal death: multiple therapeutic opportunities. Adv Anim Vet Sci 2:438–446
Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379–387
Morris J (1996) Encounters with strangers: feminism and disability. Womens Press Ltd, London
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223
Nguyen DV, Shaw L, Grant M (2012) Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol 3:170
Nickerson HD, Dutta S (2012) Diabetic complications: current challenges and opportunities. J Cardiovasc Transl Res 5:375–379
Nielsen E-MD, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glümer C et al (2003) The E23K variant of Kir6. 2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52:573–577
Okur ME, Karantas ID, Siafaka PI (2017) Diabetes Mellitus: a review on pathophysiology, current status of oral pathophysiology, current status of oral medications and future perspectives. ACTA Pharma Sci 55:482–494
Orogo AM, Gustafsson ÅB (2013) Cell death in the myocardium: my heart won’t go on. IUBMB Life 65:651–656
Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M (2016) Complications of diabetes 2016. J Diabetes Res 2016. https://doi.org/10.1155/2016/6989453
Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7:710
Peterson JW, Bö L, Mörk S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc 50:389–400
Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G et al (2010) Genetics of type 1 diabetes: what’s next? Diabetes 59:1561–1571
Poitout V, Robertson RP (2007) Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 29:351–366
Polyak K, Riggins GJ (2001) Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J Clin Oncol 19:2948–2958
Pruessner M, Hellhammer DH, Pruessner JC, Lupien SJ (2003) Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom Med 65:92–99
Radunovic A, Annane D, Jewitt K, Mustfa N (2009) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 4:CD004427
Reimer KA, Jennings RB (1981) Energy metabolism in the reversible and irreversible phases of severe myocardial ischemia. Acta Med Scand 210:19–27
Richelson E (2001) Pharmacology of antidepressants. Mayo Clin Proc 76:511–527
Sandy J (2003) Proteolytic degradation of normal and osteoarthritic cartilage matrix. Osteoarthritis 2003:82–92
Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C et al (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. elife 2:e01202
Sharma L (2003) Local mechanical factors in the natural history of knee osteoarthritis. Malalignment and joint laxity. Osteoarthritis 2:177–183
Silvers A (1998) A fatal attraction to normalizing: treating disabilities as deviations from ôspecies-typicalõ functioning. Enhanc Hum Traits 1998:95–123
Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D et al (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380:1840–1850
Stankowski JN, Gupta R (2011) Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation? Antioxid Redox Signal 14:1841–1851
Stoll G, Kleinschnitz C, Nieswandt B (2008) Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112:3555–3562
Sun X, Bromley-Brits K, Song W (2012) Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease. J Neurochem 120:62–70
Supnet C, Bezprozvanny I (2010) The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 47:183–189
Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH et al (2009) Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler 10:302–309
Suzuki Y, Brender JR, Soper MT, Krishnamoorthy J, Zhou Y, Ruotolo BT et al (2013) Resolution of oligomeric species during the aggregation of Aβ1–40 using 19F NMR. Biochemistry 52:1903–1912
Swerdlow RH, Khan SM (2004) A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Med Hypotheses 63:8–20
Talmadge JE, Fidler IJ (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70:0008–5472. CAN-10-1040
Tõugu V, Tiiman A, Palumaa P (2011) Interactions of Zn (II) and Cu (II) ions with Alzheimer’s amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. Metallomics 3:250–261
Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng Y-C et al (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 11:951–962
Van den Berg W, Van der Kraan P, Van Beuningen H (2003) Synovial mediators of cartilage damage and repair in osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis, 2nd edn. Oxford University Press, Oxford, pp 147–155
Ventura-Clapier R, Garnier A, Veksler V, Joubert F (2011) Bioenergetics of the failing heart. Biochim Biophys Acta (BBA)-Mol Cell Res 1813:1360–1372
Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579
Vucic S, Kiernan MC (2009) Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med 9:255–272
W. H. Organization (2001) International Classification of Impairment, Disability and Handicap (ICIDH-2 beta version). WHO Website, 1999, Available at (Accessed): http://www.who.int/icidh/. Date: June, 2001
Weinberg R, Hanahan D (2000) The hallmarks of cancer. Cell 100:57–70
Williamson TL, Cleveland DW (1999) Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons. Nat Neurosci 2:50
Wu N, Minden SL, Hoaglin DC, Hadden L, Frankel D (2007) Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. J Health Hum Serv Adm 30:233–267
Zanetti O, Bianchetti A, Frisoni GB, Rozzini R, Trabucchi M (1993) Determinants of disability in Alzheimer’s disease. Int J Geriatric Psychiatr 8:581–586
Zeitler P (2009) Update on nonautoimmune diabetes in children. J Clin Endocrinol Metab 94:2215–2220
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kotian, V. et al. (2019). Physical Impairments Associated with Diseases: A Pathophysiological Approach. In: Paul, S. (eds) Biomedical Engineering and its Applications in Healthcare. Springer, Singapore. https://doi.org/10.1007/978-981-13-3705-5_24
Download citation
DOI: https://doi.org/10.1007/978-981-13-3705-5_24
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3704-8
Online ISBN: 978-981-13-3705-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)